✦ LIBER ✦

P.86 PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C INFECTION IN A POPULATION OF IBD PATIENTS TREATED WITH ANTI-TUMOR NECROSIS FACTOR-α AGENTS

✍ Scribed by A. Papa; C. Felice; M. Marzo; A. Armuzzi; G. Mocci; F. Scaldaferri; G. Andrisani; L. Sparano; G. Vitale; D. Pugliese; I. De Vitis; G. Rapaccini; A. Gasbarrini; L. Guidi

Book ID: 119633795
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 79 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(10)60199-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence and natural history of hepati

Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents

✍ Papa, Alfredo; Felice, Carla; Marzo, Manuela; Andrisani, Gianluca; Armuzzi, Ales 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 391 KB

P.1.173: FORMATION OF NON-ORGAN SPECIFIC

P.1.173: FORMATION OF NON-ORGAN SPECIFIC AUTOANTIBODIES (NOSA) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) TREATED WITH ANTI-TUMOR NECROSIS FACTOR-ALPHA AGENTS

✍ I. Bravatà; M. Cappello; C. Randazzo; A. Licata; F. Barbaria; P.L. Almasio; A. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 84 KB

P.1.76: PREVALENCE AND NATURAL HISTORY O

P.1.76: PREVALENCE AND NATURAL HISTORY OF HEPATITIS B AND C VIRUS INFECTION IN A LARGE COHORT OF PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE IN TREATMENT WITH ANTI-TNF-A AGENTS

✍ A. Papa; A. Armuzzi; M. Marzo; C. Felice; G. Mocci; G. Andrisani; D. Pugliese; F 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Safety of antitumour necrosis factor-α t

Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection

✍ L. Nosotti; F. Francesconi; S. Izzi; E. Berardesca; A. Morrone; C. Bonifati 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

A comparison of response criteria to eva

A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti–tumor necrosis factor α agents

✍ A. Lurati; I. Pontikaki; B. Teruzzi; F. Desiati; V. Gerloni; M. Gattinara; R. Ci 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Use of tumor necrosis factor-α (TNF-α) a

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB